Driving innovation and advancing technology
In healthcare, reducing capital markets friction is paramount.
Our investments start early, enabling our partners to focus on advancing research and technology initiatives.
Coupled with our capital markets expertise, we leverage our network of investors and bankers to help you make strategic decisions.
The evaluation of multiple differentiating factors — the science and data behind an idea, the competitive landscape, a company's leadership and business plans — make up the core of our fundamental analysis.
We place our support behind companies we believe have a high likelihood of success and can make a significant impact on the lives of patients.
Our consistency of capital allocations begins as an early investment, with continued deployment of capital throughout the lifecycle of our portfolio companies. Read more about our capital deployment approach here.
SCIENCE. Whether early or late stage, we do not shy away from digging deep into the science. We like to see robust data demonstrating superior safety & efficacy profiles, regardless of it being a groundbreaking technology platform driving innovation or a single molecule asset.
COMPETITIVE POSITIONING. We focus on companies that have the highest likelihood of success. To do so, we map out the landscape to understand the differentiators and identify key success factors.
LEADERSHIP. Great science will never see the light of day without proper execution. We value companies that attract the right leadership and surround themselves with key advisors to ensure long-term success.
BUSINESS PLAN. We value companies with proactive rather than reactive strategies – businesses that shape the development path of therapies and enhance scaling of the business. A well-planned financing strategy is key to enable the company to stay focused on program development.